Join to View Full Profile
499 E Hampden AveSte 200Englewood, CO 80113
Phone+1 303-409-1430
Fax+1 303-781-2218
Dr. Sepesi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas MD Anderson Cancer Center/University of Texas Medical School at HoustonFellowship, Thoracic Surgery - Independent, 2011 - 2013
University of Rochester Medical CenterResidency, Surgery, 2005 - 2011
University of ColoradoResidency, Internal Medicine, 2004 - 2004
Jagiellonian University Medical CollegeClass of 2004
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2013 - 2026
CO State Medical License 2023 - 2025
OK State Medical License 2020 - 2021
NY State Medical License 2008 - 2013
American Board of Surgery Surgery
American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma Start of enrollment: 2019 Oct 02
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Enriched pathways in gut microbiome predict response to immune checkpoint inhibitor treatment across demographic regions and various cancer types.Xunhui Cai, Jennifer Y Cho, Lijun Chen, Yufeng Liu, Fenghu Ji
Iscience. 2025-04-18 - Comparison of imaging-based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed, paraffin-embedded tumor samples.Nejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez Ruiz, Wei Lu, Khaja Khan
Research Square. 2025-01-17 - 1 citationsInflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment.Zahraa Rahal, Yuejiang Liu, Fuduan Peng, Sujuan Yang, Mohamed A Jamal
Cancer Immunology Research. 2024-12-03
Authored Content
- My Top 5 Most Practice-Changing Presentations at WCLCOctober 2018
Press Mentions
Foundation Medicine Partners with Lung Cancer Research Foundation and the Lung Cancer Mutation Consortium on Screening Trial to Enable Precision TherapyJune 3rd, 2022- Circulating Cellular Determinants to Predict Response to Anti-PD-1 Monotherapy in Patients with Malignant Pleural MesotheliomaMay 15th, 2022
- Adding Atezolizumab to Neoadjuvant Cisplatin-Pemetrexed a Feasible Option in Malignant Pleural MesotheliomaOctober 15th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
